Fornaro R, Carissimi T, Belcastro E, Cambiaso C, Estienne G, Boidi M, Taviani M, Ferraris R
Cattedra di Semeiotica Chirurgica R, Università degli Studi di Genova.
Chir Ital. 1993 Feb-Dec;45(1-6):45-52.
Results of surgical and endoscopic treatment in 79 patients (58 females and 21 males, age 40-89, mean 62), affected with jaundice, due to secondary choledochal lithiasis, are reported. Thirty-four patients (43%) underwent surgical operation: choledochotomy and T-tube 12, choledocho-jejunostomy 4, choledochoduodenostomy 3, papillosphincteroplasty 15. In 45 patients (57%) EST has been performed. Comparison of results has been obtained after 30 days and after 3-105 months (mean 49). Optimal results have been achieved in 94.9% of patients: 100% after surgery and 94.1% after EST. Morbidity and mortality outcomes in patients who underwent EST (11.1% and 0% after 30 days respectively, 8.1% and 8.1% after several months) are better compared to those ones after surgical treatment (17.6% and 5.8% after 30 days, 20% and 16% after several months). We conclude that EST is nowadays the therapy of choice in patients with jaundice due to choledochal lithiasis, either relapsing or residual.
报告了79例(58例女性,21例男性,年龄40 - 89岁,平均62岁)因继发性胆总管结石而出现黄疸患者的手术及内镜治疗结果。34例(43%)患者接受了手术:胆总管切开术及T管引流12例,胆总管空肠吻合术4例,胆总管十二指肠吻合术3例,乳头括约肌成形术15例。45例(57%)患者进行了内镜下括约肌切开术(EST)。在术后30天以及3 - 105个月(平均49个月)后对结果进行了比较。94.9%的患者取得了最佳效果:手术组为100%,EST组为94.1%。与手术治疗患者相比,接受EST治疗的患者的发病率和死亡率结果更好(术后30天分别为11.1%和0%,数月后为8.1%和8.1%,而手术治疗患者术后30天为17.6%和5.8%,数月后为20%和16%)。我们得出结论,如今EST是因胆总管结石导致黄疸的患者(无论是复发性还是残留性)的首选治疗方法。